Pharmacologic effects of tetrodotoxin: cardiovascular and antiarrhythmic activities.
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000517:prevention & control; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002415:Cats; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects*; D008297:Male; D010042:Ouabain; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013779:Tetrodotoxin / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000627:therapeutic use
D010643:Phenoxybenzamine; D013779:Tetrodotoxin; D010042:Ouabain; D012110:Reserpine; D011433:Propranolol